Researchers at Baylor College of Medicine have determined that sample size (the number of individuals examined for a study) is the most important factor determining the accuracy of the study results.
Researchers at Baylor College of Medicine examined associations between dialysis facility performance with patient experience measures and patient, facility and geographic characteristics.
Researchers have been awarded three grants to continue working to identify what dangers might have been in the flood waters, and new participants are needed as well as those who have already taken part in the study.
A collaborative effort has culminated in the T32 Research Training Program in Cardiovascular Surgery in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine.
Baylor’s Center for Precision Environmental Health receives $1.58 million grant from the John S. Templeton Foundation to study a new role of the epigenome in evolution.
Baylor College of Medicine is collaborating with VistaGen Therapeutics, Inc. on a study of the anti-suicidal effects of a new VistaGen drug candidate in healthy veteran volunteers.
Puzzled by their experimental results, a team of scientists investigated why a research tool that was expected to suppress neuronal activity actually was stimulating it.
Researchers identify estrogen receptor alpha gene (ESR1) translocation events that drive not only therapeutic resistance, but also trigger ER+ breast cancer cells to metastasize.
Researchers at Baylor College of Medicine have identified a potential strategy for treating osteoarthritis from both a symptomatic and disease-modifying perspective by using gene therapy to inhibit the interleukin-1 pathway.
